CGEN
Price
$1.49
Change
+$0.02 (+1.36%)
Updated
Aug 13, 03:04 PM (EDT)
Capitalization
136.31M
85 days until earnings call
VYGR
Price
$3.69
Change
+$0.30 (+8.85%)
Updated
Aug 13, 03:06 PM (EDT)
Capitalization
188.04M
97 days until earnings call
Interact to see
Advertisement

CGEN vs VYGR

Header iconCGEN vs VYGR Comparison
Open Charts CGEN vs VYGRBanner chart's image
Compugen
Price$1.49
Change+$0.02 (+1.36%)
Volume$200
Capitalization136.31M
Voyager Therapeutics
Price$3.69
Change+$0.30 (+8.85%)
Volume$1.02K
Capitalization188.04M
CGEN vs VYGR Comparison Chart in %
Loading...
CGEN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VYGR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are Regeneron Pharmaceuticals (NASDAQ:REGN), Incyte Corp (NASDAQ:INCY), Exelixis (NASDAQ:EXEL), Moderna (NASDAQ:MRNA), Arrowhead Pharmaceuticals (NASDAQ:ARWR), Adaptive Biotechnologies Corp (NASDAQ:ADPT), Sarepta Therapeutics (NASDAQ:SRPT), Novavax (NASDAQ:NVAX), Nektar Therapeutics (NASDAQ:NKTR), Inovio Pharmaceuticals (NASDAQ:INO).

Industry description

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

Market Cap

The average market capitalization across the Biotechnology Industry is 1.79B. The market cap for tickers in the group ranges from 58 to 96.01B. VRTX holds the highest valuation in this group at 96.01B. The lowest valued company is SEELQ at 58.

High and low price notable news

The average weekly price growth across all stocks in the Biotechnology Industry was 11%. For the same Industry, the average monthly price growth was 20%, and the average quarterly price growth was 20%. SPRBD experienced the highest price growth at 6,567%, while BIVI experienced the biggest fall at -66%.

Volume

The average weekly volume growth across all stocks in the Biotechnology Industry was -12%. For the same stocks of the Industry, the average monthly volume growth was 76% and the average quarterly volume growth was 70%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 50
P/E Growth Rating: 84
Price Growth Rating: 59
SMR Rating: 93
Profit Risk Rating: 95
Seasonality Score: -14 (-100 ... +100)

Market Cap

The average market capitalization across the group is 162.18M. The market cap for tickers in the group ranges from 136.31M to 188.04M. VYGR holds the highest valuation in this group at 188.04M. The lowest valued company is CGEN at 136.31M.

High and low price notable news

The average weekly price growth across all stocks in the group was 0%. For the same group, the average monthly price growth was -5%, and the average quarterly price growth was -28%. CGEN experienced the highest price growth at 1%, while VYGR experienced the biggest fall at 0%.

Volume

The average weekly volume growth across all stocks in the group was 114%. For the same stocks of the group, the average monthly volume growth was -4% and the average quarterly volume growth was 50%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 53
P/E Growth Rating: 18
Price Growth Rating: 74
SMR Rating: 96
Profit Risk Rating: 100
Seasonality Score: -25 (-100 ... +100)
VS
CGEN vs. VYGR commentary
Aug 13, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CGEN is a Hold and VYGR is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 13, 2025
Stock price -- (CGEN: $1.47 vs. VYGR: $3.39)
Brand notoriety: CGEN and VYGR are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CGEN: 141% vs. VYGR: 114%
Market capitalization -- CGEN: $136.31M vs. VYGR: $188.04M
CGEN [@Biotechnology] is valued at $136.31M. VYGR’s [@Biotechnology] market capitalization is $188.04M. The market cap for tickers in the [@Biotechnology] industry ranges from $96.01B to $0. The average market capitalization across the [@Biotechnology] industry is $1.79B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CGEN’s FA Score shows that 1 FA rating(s) are green whileVYGR’s FA Score has 2 green FA rating(s).

  • CGEN’s FA Score: 1 green, 4 red.
  • VYGR’s FA Score: 2 green, 3 red.
According to our system of comparison, VYGR is a better buy in the long-term than CGEN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CGEN’s TA Score shows that 4 TA indicator(s) are bullish while VYGR’s TA Score has 7 bullish TA indicator(s).

  • CGEN’s TA Score: 4 bullish, 6 bearish.
  • VYGR’s TA Score: 7 bullish, 2 bearish.
According to our system of comparison, VYGR is a better buy in the short-term than CGEN.

Price Growth

CGEN (@Biotechnology) experienced а +0.68% price change this week, while VYGR (@Biotechnology) price change was +0.30% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +11.28%. For the same industry, the average monthly price growth was +20.14%, and the average quarterly price growth was +20.02%.

Reported Earning Dates

CGEN is expected to report earnings on Nov 06, 2025.

VYGR is expected to report earnings on Nov 18, 2025.

Industries' Descriptions

@Biotechnology (+11.28% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
VYGR($188M) has a higher market cap than CGEN($136M). CGEN has higher P/E ratio than VYGR: CGEN (64.00) vs VYGR (6.00). CGEN YTD gains are higher at: -3.922 vs. VYGR (-40.212). CGEN has higher annual earnings (EBITDA): -14.79M vs. VYGR (-97.25M). VYGR has more cash in the bank: 236M vs. CGEN (104M). CGEN has less debt than VYGR: CGEN (2.77M) vs VYGR (42M). VYGR has higher revenues than CGEN: VYGR (67M) vs CGEN (27.6M).
CGENVYGRCGEN / VYGR
Capitalization136M188M72%
EBITDA-14.79M-97.25M15%
Gain YTD-3.922-40.21210%
P/E Ratio64.006.001,067%
Revenue27.6M67M41%
Total Cash104M236M44%
Total Debt2.77M42M7%
FUNDAMENTALS RATINGS
CGEN vs VYGR: Fundamental Ratings
CGEN
VYGR
OUTLOOK RATING
1..100
774
VALUATION
overvalued / fair valued / undervalued
1..100
75
Overvalued
32
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9696
PRICE GROWTH RATING
1..100
6286
P/E GROWTH RATING
1..100
2610
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

VYGR's Valuation (32) in the Biotechnology industry is somewhat better than the same rating for CGEN (75). This means that VYGR’s stock grew somewhat faster than CGEN’s over the last 12 months.

VYGR's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as CGEN (100). This means that VYGR’s stock grew similarly to CGEN’s over the last 12 months.

VYGR's SMR Rating (96) in the Biotechnology industry is in the same range as CGEN (96). This means that VYGR’s stock grew similarly to CGEN’s over the last 12 months.

CGEN's Price Growth Rating (62) in the Biotechnology industry is in the same range as VYGR (86). This means that CGEN’s stock grew similarly to VYGR’s over the last 12 months.

VYGR's P/E Growth Rating (10) in the Biotechnology industry is in the same range as CGEN (26). This means that VYGR’s stock grew similarly to CGEN’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CGENVYGR
RSI
ODDS (%)
Bullish Trend 2 days ago
83%
N/A
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
83%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
77%
MACD
ODDS (%)
Bullish Trend 2 days ago
84%
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 2 days ago
79%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
86%
Advances
ODDS (%)
Bullish Trend 13 days ago
81%
Bullish Trend 8 days ago
79%
Declines
ODDS (%)
Bearish Trend 15 days ago
90%
Bearish Trend 3 days ago
85%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 2 days ago
90%
Aroon
ODDS (%)
Bearish Trend 2 days ago
89%
Bullish Trend 2 days ago
81%
View a ticker or compare two or three
Interact to see
Advertisement
CGEN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VYGR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
RTOXF4.610.49
+11.89%
Rotork PLC
ITMPF0.860.01
+1.07%
ITM Power Plc
SMTOY27.190.27
+1.02%
Sumitomo Electric Industries Ltd.
MBGPF0.94N/A
N/A
MOBERG PHARMA AB
SVIN3.21-0.10
-2.90%
Scheid Vineyards Inc.

CGEN and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, CGEN has been loosely correlated with NURPF. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if CGEN jumps, then NURPF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CGEN
1D Price
Change %
CGEN100%
-2.00%
NURPF - CGEN
46%
Loosely correlated
N/A
BDTX - CGEN
44%
Loosely correlated
+9.96%
ARWR - CGEN
42%
Loosely correlated
+3.43%
ROIV - CGEN
41%
Loosely correlated
+3.58%
ASPHF - CGEN
41%
Loosely correlated
N/A
More

VYGR and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, VYGR has been loosely correlated with RGNX. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if VYGR jumps, then RGNX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VYGR
1D Price
Change %
VYGR100%
+10.06%
RGNX - VYGR
50%
Loosely correlated
+8.58%
KYMR - VYGR
49%
Loosely correlated
+5.81%
XNCR - VYGR
49%
Loosely correlated
+10.71%
XENE - VYGR
47%
Loosely correlated
+5.51%
IMNM - VYGR
46%
Loosely correlated
+2.59%
More